The quest for earlier, more accurate detection of neurodegenerative diseases has received a fresh injection of capital. eNLife Research Private Limited has successfully closed a Seed funding round, securing $720K to advance its work in this critical medical area.
The startup is focused on developing innovative, accessible, and accurate diagnostic tools designed to empower healthcare providers and patients. This new capital will help eNLife Research bring its solutions closer to market, aiming to provide actionable insights for better outcomes in conditions where early intervention can be crucial.
